Gravity Analytica

Lilly announces changes on board of directors

LLY 11.19.2024

Full Press Release SEC Filings Our LLY Tweets

About Gravity Analytica

Recent Filings

INDIANAPOLIS,Nov. 19, 2024/PRNewswire/ --Eli Lilly and Company(NYSE: LLY) announced today that it has electedJon Moelleras a new member of its board of directors, effectiveDec. 1, 2024. In addition, the company announced thatKaren Walkerwill transition her role with Lilly, resigning as a member of Lilly's board of directors effectiveDec. 31, 2024. In 2025,Ms. Walkerwill collaborate with Lilly on certain digital commercial activities.

Mr. Moelleris the chairman of the board, president and chief executive officer of Procter &Gamble(P&G). A strong leader who has served as an integral part of P&G's leadership team for more than two decades,Mr. Moellerhas held key positions within finance, business and strategy functions, serving as vice chairman, chief financial officer and chief operating officer, with responsibility for the company's developing markets and global operations. He also serves on the boards of theBusiness Roundtable, theConsumer Goods Forum, and Catalyst, a global non-profit that accelerates progress for women through workplace inclusion.Mr. Moellerwill serve on the Lilly Audit Committee and theDirectors and Corporate Governance Committeeand will stand for election by Lilly shareholders at the company's annual meeting inMay 2026.

"I am honored to welcomeJon Moellerto our board of directors," saidDavid A. Ricks, Lilly chair and CEO. "As the CEO of an iconic American company with global reach, Jon brings deep expertise in driving strategic and operational excellence at scale. His long-standing success in leading a consumer-centric organization and providing expert counsel will offer valuable perspective to our board."

Ms. Walkerhas served on Lilly's board since 2018, including as a member of the board's Audit and Talent and Compensation Committees. She has brought her unique experience in brand-building and go-to-market strategy to the board during a period of significant growth for Lilly, serving as an active mentor to many of Lilly's leaders and providing valuable insight on talent development. The board and executive committee have greatly valued her perspective as an operating partner with The Goldman Sachs Group and as the former chief marketing officer of both Intel Corporation and Cisco Systems. The board also has benefited from her keen understanding of technology strategy.

"Karen has been an instrumental part of Lilly's board during her tenure, and on behalf of the entire board, I thank her for her guidance, mentorship and insights during this important period in Lilly's history," said Ricks. "We are grateful that she will continue to contribute to Lilly's growth as we scale our digital and commercial capabilities."

About LillyLilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visitLilly.comandLilly.com/news, or follow us onFacebook,Instagram, andLinkedIn. C-LLY

Refer to:	Carrie Munk;munk_carrie@lilly.com; 317-416-2393 (Media)
	Michael Czapar;czapar_michael_c@lilly.com; 317-617-0983 (Investors)

View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-announces-changes-on-board-of-directors-302310590.html

SOURCEEli Lilly and Company

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com

Lilly announces changes on board of directors

LLY 11.19.2024

About Gravity Analytica

Recent News

Recent Filings